Search Orphan Drug Designations and Approvals
-
Generic Name: | Nine amino acid polypeptide derived from proteinase 3 |
---|---|
Date Designated: | 09/03/2004 |
Orphan Designation: | Treatment of myelodysplastic syndromes requiring therapy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
The Vaccine Company P. O. Box 93921 Carmel, California 93921 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-